Skip to main content
SUPHA PHARMACHEM LIMITED logo

SUPHA PHARMACHEM LIMITED — Investor Relations & Filings

Ticker · 539561 ISIN · INE549S01036 BSE.NS Manufacturing
Filings indexed 444 across all filing types
Latest filing 2026-05-12 Regulatory Filings
Country IN India
Listing BSE.NS 539561

About SUPHA PHARMACHEM LIMITED

https://www.remlife.com

Supha Pharmachem Limited specializes in the development, manufacture, and distribution of Active Pharmaceutical Ingredients (APIs) and advanced intermediates. The company maintains manufacturing facilities equipped to adhere to international quality standards and Good Manufacturing Practices (GMP). Its core operations involve complex chemical synthesis and process optimization to support various therapeutic categories within the pharmaceutical supply chain. Supha Pharmachem focuses on delivering high-purity chemical components to a global client base, leveraging its research and development capabilities to ensure product efficacy and regulatory compliance. The organization provides technical support and customized solutions for the production of essential medicinal compounds, serving as a strategic supplier for formulation manufacturers worldwide.

Recent filings

Filing Released Lang Actions
Appointment of Resolution Professional in place of Interim Resolution Professional
Regulatory Filings Classification · 85% confidence The document is a formal notice to the BSE Limited informing the stock exchange of a change in the Company’s Insolvency Professional (RP replacing IRP) pursuant to a National Company Law Tribunal order. It does not contain financial statements or detailed report content, but rather serves as a regulatory announcement to satisfy listing obligations. It is neither an actual annual/interim report nor a detailed management or legal proceeding report, but a compliance notice. Therefore, it falls under Regulatory Filings (RNS).
2026-05-12 English
Disclosure to take note of decisions taken in 1st COC meeting held on 14.04.2026
Regulatory Filings
2026-04-17 English
This disclosure is to place on record List of Creditors as required to be placed under Reg 13(2)(c) of IBBI CIRP Regulations
Regulatory Filings
2026-04-10 English
Update on CIRP Proceedings, Non-Cooperation by Directors (Power suspended) and Postponement of Board Meeting under Regulation 30 of SEBI (LODR) Regulation, 2015
Regulatory Filings
2026-04-02 English
Closure of Trading window
Regulatory Filings
2026-03-25 English
Intimation of receipt of Order from National Company Law Tribunal (NCLT)
Regulatory Filings
2026-03-21 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.